oxidopamine has been researched along with Teratoma in 3 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Teratoma: A true neoplasm composed of a number of different types of tissue, none of which is native to the area in which it occurs. It is composed of tissues that are derived from three germinal layers, the endoderm, mesoderm, and ectoderm. They are classified histologically as mature (benign) or immature (malignant). (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1642)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moon, J | 1 |
| Schwarz, SC | 1 |
| Lee, HS | 1 |
| Kang, JM | 1 |
| Lee, YE | 1 |
| Kim, B | 1 |
| Sung, MY | 1 |
| Höglinger, G | 1 |
| Wegner, F | 1 |
| Kim, JS | 1 |
| Chung, HM | 1 |
| Chang, SW | 1 |
| Cha, KY | 1 |
| Kim, KS | 1 |
| Schwarz, J | 1 |
| Chang, YL | 1 |
| Chen, SJ | 1 |
| Kao, CL | 1 |
| Hung, SC | 1 |
| Ding, DC | 1 |
| Yu, CC | 1 |
| Chen, YJ | 1 |
| Ku, HH | 1 |
| Lin, CP | 1 |
| Lee, KH | 1 |
| Chen, YC | 1 |
| Wang, JJ | 1 |
| Hsu, CC | 1 |
| Chen, LK | 1 |
| Li, HY | 1 |
| Chiou, SH | 1 |
| Parish, CL | 1 |
| Parisi, S | 1 |
| Persico, MG | 1 |
| Arenas, E | 1 |
| Minchiotti, G | 1 |
3 other studies available for oxidopamine and Teratoma
| Article | Year |
|---|---|
Preclinical Analysis of Fetal Human Mesencephalic Neural Progenitor Cell Lines: Characterization and Safety In Vitro and In Vivo.
Topics: Animals; Biomarkers; Cell Culture Techniques; Cell Line; Cell Proliferation; Disease Models, Animal; | 2017 |
Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; Cells, Cultured; Docosahexaenoic A | 2012 |
Cripto as a target for improving embryonic stem cell-based therapy in Parkinson's disease.
Topics: Animals; Brain; Brain Neoplasms; Cell Differentiation; Dopamine; Embryo, Mammalian; Epidermal Growth | 2005 |